Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588–97.

Article  PubMed  PubMed Central  Google Scholar 

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2023 update: a report from the American Heart Association [published correction appears in Circulation. 2023;147:e622]. Circulation. 2023;147:e93–621.

Article  PubMed  PubMed Central  Google Scholar 

Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023;54(7):e314–70. https://doi.org/10.1161/STR.0000000000000436.

Article  PubMed  Google Scholar 

Qureshi AI, Lobanova I, Huang W, et al. Lessons learned from phase II and phase III trials investigating therapeutic agents for cerebral ischemia associated with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2022;36:662–81.

Article  PubMed  Google Scholar 

Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–96.

Article  CAS  PubMed  Google Scholar 

Claassen J, Park S. Spontaneous subarachnoid haemorrhage. Lancet. 2022;400:846–62.

Article  PubMed  PubMed Central  Google Scholar 

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618–25.

Article  CAS  PubMed  Google Scholar 

Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):CD000277. https://doi.org/10.1002/14651858.CD000277.

Article  PubMed  PubMed Central  Google Scholar 

Wong GK, Boet R, Poon WS, Chan MT, Gin T, Ng SC, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care. 2011;15:R52. https://doi.org/10.1186/cc10017.

Article  PubMed  PubMed Central  Google Scholar 

Qureshi AI, Akhtar IN, Ma X, Lodhi A, Bhatti I, Beall J, et al. Effect of Cilostazol in animal models of cerebral ischemia and subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2022. https://doi.org/10.1007/s12028-022-01637-6.

Article  PubMed  Google Scholar 

Xie Y, Liu W, Zhang X, Wang L, Xu L, Xiong Y, et al. Human albumin improves long-term behavioral sequelae after subarachnoid hemorrhage through neurovascular remodeling. Crit Care Med. 2015;43:e440–9.

Article  PubMed  Google Scholar 

Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43:683–90.

Article  PubMed  PubMed Central  Google Scholar 

Suarez JI, Martin RH, Calvillo E, Bershad EM, Venkatasubba Rao CP. Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study. Acta Neurochir Suppl. 2015;120:287–90.

Article  PubMed  Google Scholar 

Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res. 2002;24(5):510–6. https://doi.org/10.1179/016164102101200276. (PMID: 12117325.).

Article  PubMed  Google Scholar 

Encarnacion A, Horie N, Keren-Gill H, Bliss TM, Steinberg GK, Shamloo M. Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods. 2011;196:247–57.

Article  PubMed  PubMed Central  Google Scholar 

Madinier A, Quattromani MJ, Sjölund C, Ruscher K, Wieloch T. Enriched housing enhances recovery of limb placement ability and reduces aggrecan-containing perineuronal nets in the rat somatosensory cortex after experimental stroke. PLoS ONE. 2014;9:e93121.

Article  PubMed  PubMed Central  Google Scholar 

Lenzlinger PM, Saatman KE, Hoover RC, Cheney JA, Bareyre FM, Raghupathi R, et al. Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling by BSF476921 attenuates regional cerebral edema following traumatic brain injury in rats. Restor Neurol Neurosci. 2004;22:73–9.

CAS  PubMed  Google Scholar 

Hasegawa Y, Suzuki H, Altay O, Zhang JH. Preservation of tropomyosin-related kinase B (TrkB) signaling by sodium orthovanadate attenuates early brain injury after subarachnoid hemorrhage in rats. Stroke. 2011;42:477–83.

Article  CAS  PubMed  Google Scholar 

Hasegawa Y, Suzuki H, Nakagawa T, Uekawa K, Koibuchi N, Kawano T, et al. Assessment of the correlations between brain weight and brain edema in experimental subarachnoid hemorrhage. Acta Neurochir Suppl. 2016;121:89–92.

Article  PubMed  Google Scholar 

Kim JE, Lee RP, Yazigi E, Atta L, Feghali J, Pant A, et al. Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke. Brain Behav Immun. 2024;116:160–74. https://doi.org/10.1016/j.bbi.2023.12.007. (Epub 2023 Dec 7. PMID: 38070624; PMCID: PMC11220828.).

Article  CAS  PubMed  Google Scholar 

Kara F, Dongen ES, Schliebs R, Buchem MA, Groot HJ, Alia A. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer’s disease by in vivo magnetic resonance angiography at 17.6 T. Neuroimage. 2012;60:958–66.

Article  CAS  PubMed  Google Scholar 

Mielke D, Bleuel K, Stadelmann C, Rohde V, Malinova V. The ESAS-score: a histological severity grading system of subarachnoid hemorrhage using the modified double hemorrhage model in rats. PLoS ONE. 2020;15(2):e0227349. https://doi.org/10.1371/journal.pone.0227349. (PMID: 32097426; PMCID: PMC7041796.).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mutoh T, Mutoh T, Sasaki K, Nakamura K, Taki Y, Ishikawa T. Value of three-dimensional maximum intensity projection display to assist in magnetic resonance imaging (MRI)-Based grading in a mouse model of subarachnoid hemorrhage. Med Sci Monit. 2016;22:2050–5. https://doi.org/10.12659/msm.896499. (PMID: 27307024; PMCID: PMC4913823.).

Article  PubMed  PubMed Central  Google Scholar 

Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012–20. https://doi.org/10.1161/hs0901.095677. (PMID: 11546890.).

Article  CAS  PubMed  Google Scholar 

Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389:655–66.

Article  PubMed  Google Scholar 

Springer MV, Schmidt JM, Wartenberg KE, Frontera JA, Badjatia N, Mayer SA. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043–51.

Article  PubMed  Google Scholar 

Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.

Article  PubMed  Google Scholar 

Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14:599–608.

Article  CAS  PubMed  Google Scholar 

de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44:43–54.

Article  PubMed